<DOC>
	<DOC>NCT00480896</DOC>
	<brief_summary>A long-term 0.03% tacrolimus ointment based regimen comprising of up to 6 weeks of initial twice daily treatment and subsequent twice weekly prophylactic application can effectively treat active lesions of atopic dermatitis, and prevent, delay, and reduce flares.</brief_summary>
	<brief_title>Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis, Atopic</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Male or female patient of any ethnic group Patient was at least 215 years old and suffered from mild to severe atopic dermatitis (Rajka/Langeland score of at least 3) Patient had a genetic epidermal barrier defect such as Netherton's syndrome or generalised erythroderma Patient had a clinically significant skin infection on the affected (and to be treated) area</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Dermatitis, atopic</keyword>
	<keyword>Tacrolimus</keyword>
	<keyword>Child</keyword>
	<keyword>treatment outcomes</keyword>
</DOC>